Cameco Corporation $CCJ is Stanley Laman Group Ltd.'s 7th Largest Position

Key Points

• Stanley Laman Group Ltd. trimmed its stake in Cameco by 9.5%, selling 14,749 shares and holding 140,075 shares (about $12.82M), making CCJ its 7th-largest position (1.6% of the portfolio).
• Other institutions raised exposure—UBS Asset Management added 64,512 shares to hold 604,841 shares and NewGen opened a new ~$14.25M position—leaving about 70.21% of the stock owned by institutional investors.
• Analysts rate Cameco a Moderate Buy with an average price target of $150.40 after the company beat quarterly EPS and revenue estimates; shares recently traded near $116.15.

Stanley Laman Group Ltd. lowered its stake in shares of Cameco Corporation (NYSE:CCJ - Free Report) TSE: CCO by 9.5% in the fourth quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm owned 140,075 shares of the basic materials company's stock after selling 14,749 shares during the period. Cameco comprises about 1.6% of Stanley Laman Group Ltd.'s investment portfolio, making the stock its 7th biggest holding. Stanley Laman Group Ltd.'s holdings in Cameco were worth $12,815,000 as of its most recent filing with the Securities & Exchange Commission.

A number of other hedge funds have also modified their holdings of CCJ. Bison Wealth LLC increased its stake in shares of Cameco by 16.1% in the fourth quarter. Bison Wealth LLC now owns 21,448 shares of the basic materials company's stock worth $1,102,000 after acquiring an additional 2,975 shares during the last quarter. AQR Capital Management LLC increased its stake in shares of Cameco by 16.6% in the first quarter. AQR Capital Management LLC now owns 9,547 shares of the basic materials company's stock worth $393,000 after acquiring an additional 1,361 shares during the last quarter. Integrated Wealth Concepts LLC increased its stake in shares of Cameco by 48.7% in the first quarter. Integrated Wealth Concepts LLC now owns 8,485 shares of the basic materials company's stock worth $349,000 after acquiring an additional 2,780 shares during the last quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC increased its stake in shares of Cameco by 11.9% in the first quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 604,841 shares of the basic materials company's stock worth $24,895,000 after acquiring an additional 64,512 shares during the last quarter. Finally, NewGen Equity Long Short Fund acquired a new position in shares of Cameco in the second quarter worth $14,252,000. 70.21% of the stock is owned by institutional investors and hedge funds.

Wall Street Analyst Weigh In

A number of equities analysts have recently weighed in on CCJ shares. Royal Bank Of Canada upped their price target on shares of Cameco from $150.00 to $160.00 and gave the stock an "outperform" rating in a research note on Tuesday, February 17th. The Goldman Sachs Group reaffirmed a "buy" rating and issued a $131.00 price target on shares of Cameco in a research note on Wednesday, February 4th. Weiss Ratings raised shares of Cameco from a "hold (c)" rating to a "buy (b-)" rating in a research note on Monday, February 23rd. Canadian Imperial Bank of Commerce upped their price target on shares of Cameco to $202.00 in a research note on Monday, March 9th. Finally, Glj Research reaffirmed a "buy" rating and issued a $171.20 price target (up from $100.00) on shares of Cameco in a research note on Wednesday, February 18th. Eleven research analysts have rated the stock with a Buy rating and three have given a Hold rating to the stock. According to data from MarketBeat.com, Cameco has a consensus rating of "Moderate Buy" and an average price target of $150.40.

Cameco Trading Up 0.1%

Shares of NYSE:CCJ opened at $116.15 on Monday. The stock has a market capitalization of $50.59 billion, a PE ratio of 119.74 and a beta of 1.02. Cameco Corporation has a 1 year low of $38.59 and a 1 year high of $135.24. The firm has a fifty day moving average price of $113.96 and a 200 day moving average price of $102.04. The company has a current ratio of 2.47, a quick ratio of 1.68 and a debt-to-equity ratio of 0.14.

Cameco (NYSE:CCJ - Get Free Report) TSE: CCO last issued its quarterly earnings data on Friday, February 13th. The basic materials company reported $0.36 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $0.29 by $0.07. The firm had revenue of $874.57 million during the quarter, compared to analysts' expectations of $782.13 million. Cameco had a net margin of 17.00% and a return on equity of 9.35%. Cameco's revenue for the quarter was up 1.5% on a year-over-year basis. During the same period in the prior year, the company posted $0.36 earnings per share. Analysts expect that Cameco Corporation will post 1.27 EPS for the current fiscal year.

Cameco Company Profile

Cameco Corporation NYSE: CCJ is a leading producer of uranium and a supplier to the global nuclear power industry. Headquartered in Saskatoon, Saskatchewan, Canada, the company is engaged in the exploration, mining, milling and sale of uranium concentrate, commonly known as yellowcake, which is used as fuel for nuclear reactors. Cameco also participates in services and activities that support the front end of the nuclear fuel cycle, including processing and marketing of uranium to utilities under long‑term and spot contracts.

The company's operations have historically centered in Canada and the United States, where it operates and develops uranium mining and processing properties.

Want to see what other hedge funds are holding CCJ? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Cameco Corporation (NYSE:CCJ - Free Report) TSE: CCO.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.